Individualised prediction of chemotherapy benefit in early-onset colorectal cancer
We developed a clinical risk model by combining different risk factors, which can accurately screen those with high-risk EOCRC for benefit from chemotherapy. For low-risk EOCRC patients, our results did not observe a better survival benefit from chemotherapy, and more prospective studies are needed in the future to prove our conclusions.
Authors
- Cheng Zhang (ORCID: https://orcid.org/0000-0002-1857-3961)
- Dan Tong (ORCID: https://orcid.org/0000-0003-3787-0707)
- Peng Lv (ORCID: https://orcid.org/0000-0001-9219-3337)
- Jian Li (ORCID: https://orcid.org/0000-0001-7901-5413)
- Peng Xu (ORCID: https://orcid.org/0009-0009-5669-8106)
Institutions
- General Hospital of Shenyang Military Region (CN)
- China Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1007/s12672-024-01490-3
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00